Bloomage Biotech demonstrated its industry leadership with its cutting-edge bioactive ingredients at the 2023 International Consumer Products Expo held in Haikou from April 10 to 15. The International Consumer Products Expo is the premier event for consumer goods in the Asia-Pacific region, hosting over 3,100 brands from 65 countries and territories. This year's expo emphasized the importance of strengthening relationships between buyers and exhibitors, serving as a catalyst for international trade and cooperation.

Over 2,000 overseas buyers representing 35 countries and regions attended the event as a testament to the expo's motto "Buy globally, sell globally." As an esteemed participant, Bloomage Biotech showcased a comprehensive collection of high-quality bioactive raw materials catering to a diverse range of industries such as pharmaceuticals, cosmetics, and food. Since its inception, the company has been a trailblazer in the global market for hyaluronic acid and related products, gaining recognition as a world-renowned hyaluronic acid manufacturer by 2007. Through revolutionary developments in microbial fermentation, the company has significantly increased hyaluronic acid production yields while reducing costs.

Further innovations led to the world's first patent enzymatic degradation technology for producing oligo sodium hyaluronate, ensuring precise control over molecular volume and expanding the range of potential applications. With its advanced production capabilities, Bloomage Biotech offers over 200 hyaluronic acid products, including pharmaceutical, cosmetic, and food-grade varieties. The company's innovations have been widely applied in medicine, medical devices, cosmetics, and nutrition.

Additionally, the company has ventured into new applications, including pet care, reproductive health, oral care, textiles, and paper products, providing a diverse selection of raw materials to meet the evolving needs of global industries. Bloomage Biotech is also making strides in other bioactive ingredient domains. The company currently boasts a library of approximately 500 active substances, with 100 currently in active development.

Under its diversified raw material strategy, the company offers highly sought-after bioactive ingredients like GABA, Ectoine, Ergothioneine, and Cordyceps Militaris Ferment Filtrate.